Canopy Growth (CGC) Interest Expenses (2019 - 2026)
Canopy Growth (CGC) posted Interest Expenses of $1.1 billion for Q1 2026, up 5828.55% sequentially from $18.6 million in Q4 2025, and up 7.07% YoY from $1.0 billion in Q1 2025.
Canopy Growth (CGC) Interest Expenses (2019 - 2026) Analysis & Trends
Canopy Growth has reported Interest Expenses for 8 years, with the latest figure at $1.1 billion in Q1 2026.
- Quarterly Interest Expenses rose 7.07% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 7.07% YoY) and the FY2026 annual result came in at $1.1 billion, up 7.07% from the prior year.
- Interest Expenses climbed to $1.1 billion in Q1 2026 per CGC's latest filing, from $18.6 million in the prior quarter.
- Over five years, Interest Expenses peaked at $1.1 billion in Q1 2026 and troughed at $6.4 million in Q3 2025.
- A 5-year average of $142.1 million and a median of $20.4 million in 2023 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 5385.14% in 2025, down 59.0% in 2025.
- Over 5 years, Interest Expenses stood at $24.5 million in 2022, then slipped by 26.24% to $18.1 million in 2023, then slumped by 33.64% to $12.0 million in 2024, then soared by 54.62% to $18.6 million in 2025, then surged by 5828.55% to $1.1 billion in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.1 billion, $18.6 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 9.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.16 Mn |
| Jun 30, 2026 | 9.16 Mn |
| Mar 31, 2026 | 1.10 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 18.56 Mn |
| Dec 31, 2025 | 18.56 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 7.03 Mn |
| Mar 31, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 15.60 Mn |
| Sep 30, 2024 | 15.60 Mn |
| Jun 30, 2024 | 15.46 Mn |
| Jun 30, 2024 | 15.46 Mn |
| Mar 31, 2024 | 18.73 Mn |
| Mar 31, 2024 | 18.73 Mn |